Roivant Sciences Ltd (ROIV)
Days of sales outstanding (DSO)
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | — | 143.89 | 5.54 | 1.91 | 1.97 | 2.26 | 2.58 | 1.97 | 1.63 | 1.46 | 1.84 | — | 8.21 | 5.30 | 3.46 | 5.54 | 1.72 | — | |
DSO | days | — | 2.54 | 65.88 | 190.94 | 184.81 | 161.78 | 141.23 | 185.39 | 224.22 | 249.28 | 198.13 | — | 44.44 | 68.86 | 105.48 | 65.91 | 212.17 | — |
March 31, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days sales outstanding (DSO) for Roivant Sciences Ltd has shown considerable variability over the periods from December 31, 2020, to March 31, 2025.
The DSO value was not available for December 31, 2020, and June 30, 2022, but for the periods where data is present, there are fluctuations in DSO. The highest DSO was recorded on December 31, 2022, at 249.28 days, indicating a longer average collection period for accounts receivable during that period. Conversely, the lowest DSO was on December 31, 2024, at 2.54 days, signifying a significantly quicker collection of sales in that period.
We observe improvements in collection efficiency as DSO decreased from 212.17 days on March 31, 2021, to 44.44 days on March 31, 2022. However, there was an increase in DSO to 185.39 days on June 30, 2023, followed by a decline to 2.54 days on December 31, 2024.
Overall, fluctuations in DSO can suggest changes in the company's credit policies, efficiency of collections, or the quality of accounts receivable management. It is important for Roivant Sciences Ltd to manage its DSO effectively to ensure timely collection of receivables and maintain a healthy cash flow position.
Peer comparison
Mar 31, 2025